logo2 (29K) spacer.gif - 1kb Top Commissions, Great Re-orders, Best Support & Promotions


CLICK FOR SPECIAL REMEDY REPORTS...
Acid Reflux & Heartburn | ADHD/ADD | Diabetes Reversal | Ed / Impotence | Gallstone | Gout | Graves' Disease | Herpes Relief | High Bood Pressure | Kidney Stones | Lyme Disease | Scabies | Urinary Tract Infection

BOOK MARK AND SHARE THIS ARTICLE

Ziconotide Syrup (Ziconotide capsule) Information

By: alien

What is Ziconotide and for what Ziconotide is used?

Ziconotide medication belong to Analgesic class. Ziconotide undetermined; however, animal data indicate that ziconotide blocks N-type calcium channels by binding to them, which leads to blockade of excitatory neurotransmitter release in primary afferent nerve terminals and antinociception.

How to Take Ziconotide

Take Ziconotide exactly as prescribed by health care provider. Ziconotide is generally available in market in the form Blisters of powder for oral inhalation 5 mg. For intrathecal (IT) administration only using programmable implanted variable-rate microinfusion device or an external microinfusion device and catheter. Not for intradermal, subcutaneous, IM, IV, intra-arterial, or oral administration. Saline solutions containing preservatives are not appropriate for IT drug administration and should not be used. Initial dose is 2.4 mcg/day (0.1 mcg/hr). Dose is adjusted upward by up to 2.4 mcg/day (0.1 mcg/hr) at intervals of no more than 2 to 3 times/wk, based on patient's severity of pain, response to therapy, and occurrence of adverse effects. Dose increases in increments of less than 2.4 mcg/day (0.1 mcg/hr) and increases in dose less frequently than 2 to 3 times/wk may be used. Recommended max dose is 19.2 mcg/day (0.8 mcg/hr).

Dosage Instructions for Ziconotide Drug

Management of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment. Preexisting history of psychosis; infection at the microinfusion injection site, uncontrolled bleeding diathesis, spinal canal obstruction that impairs circulation of CSF, hypersensitivity to any component of the product.

Interactions of Ziconotide with other drugs

Alcohol, other CNS depressants: Additive or potentiation of CNS depressant effects.
Cimetidine: May elevate Ziconotide plasma levels, increasing the therapeutic and adverse effects.
Rifampin: May reduce Ziconotide plasma levels, reducing the effectiveness.

What are the Side Effects of Ziconotide -

Like other medicines, Ziconotide can cause side effects. Some of the more common side effects of Ziconotide include

* Hypertension, hypotension, postural hypotension, syncope, tachycardia, vasodilation (at least 2%); atrial fibrillation (less than 2%).
* Dizziness (47%); confusion (33%); asthenia, memory impairment, somnolence, (22%); ataxia (16%); abnormal gait, headache (15%); speech disorder (14%); aphasia, hallucinations (12%); hypertonia (11%); anxiety (9%); nystagmus, abnormal thinking (8%); dysesthesia, hallucinations, nervousness, paresthesia, vertigo (7%); paranoid reactions (3%);
* Nausea (41%); diarrhea (19%); vomiting (15%); anorexia (10%); constipation, dry mouth, dyspepsia, GI disorder, taste perversion (at least 2%).
* Dehydration, hypokalemia, increased creatinine phosphokinase, peripheral edema, weight loss (at least 2%).
* Pain (11%); fever (7%); abdominal pain, accidental injury, catheter complication, catheter site pain, cellulitis, chest pain, chills, edema, fever, flu syndrome, infection, pain, pump site complication, mass, or pain, viral infection (at least 2%); sepsis (less than 2%).

Warnings and precautions before taking Ziconotide :

* Severe psychiatric symptoms and neurological impairment may occur with ziconotide treatment. Frequently monitor all patients for evidence of cognitive impairment, hallucinations, or changes in mood or consciousness. If necessary, therapy can be interrupted or discontinued abruptly without evidence of withdrawal.
* To reduce risk of meningitis and other infections, ensure patient or caregiver with external microinfusion device is familiar with handling of the device and care of the catheter skin exit site.
* Advise patient before taking Ziconotide that medication usually is started at a low dose and then gradually increased as tolerated until max benefit is obtained.
* Instruct patient to continue to take other medications for pain as prescribed by health care provider.
* Advise patient before taking Ziconotide to notify health care provider immediately if any of the following occur: change in mental status (eg, confusion, decreased alertness, disorientation, lethargy); change in mood or perceptions; symptoms of depression of suicidal ideation; symptoms of meningitis (eg, fever, headache, nausea, seizures, stiff neck, vomiting); new or worsening muscle pain, soreness, or weakness.
* Caution patient that alcohol and other CNS depressants (eg, sedatives) will have additional sedative effects if taken while on ziconotide therapy.
* Caution patient to avoid engaging in driving or performing other activities requiring complete mental alertness or motor coordination during treatment with ziconotide.
* Advise women to inform health care provider if pregnant, planning to become pregnant, or breastfeeding.
* Advise patient before taking Ziconotide not to take any prescription or OTC medications, dietary supplements, or herbal preparations unless advised by health care provider.
* Advise patient before taking Ziconotide that follow-up visits and lab tests will be required to monitor therapy and to keep appointments.
* Caution patient before taking Ziconotide to inform the health care provider if pregnant, planning to become pregnant, or breastfeeding.

What if Overdose of Ziconotide ?

If you think you or anyone else taken overdose of Ziconotide , immediately telephone your doctor or contact your local or regional Poisons Information Centre Seek medical attention immediately. You may need urgent medical attention. Ataxia, confusion, dizziness, garbled speech, hypotension, nausea, nystagmus, sedation, spinal myoclonus, stupor, unresponsiveness, vomiting, word-finding difficulties are may be the overdose symptoms of Ziconotide .

What if Missed Dose of Ziconotide ?

If you miss a dose of Ziconotide medicine and you remember within an hour or so, take the dose immediately. If you do not remember until later, skip the dose you missed and go back to your regular schedule. Do not double doses.

Storage Conditions for Ziconotide :

Store Ziconotide in refrigerator (36° to 46°F). Ziconotide diluted with saline may be stored in refrigerator but infusion should begin with 24 hr of preparation. Do not freeze. Protect from light.


Alien writes for Cymbalta . Check out for cymbalta uses and cymbalta side effects .

Article Source: http://www.wellnessarticlelibrary.com



Please Rate this Article

 

Not yet Rated

Click the XML Icon Above to Receive - drugs Articles Via RSS!


More of our Article Directories:



HOT PROMO VIDEOS IN MINUTES FROM YOUR DESKTOP...



CLICK HERE NOW FOR FREE DETAILS ON THE NEWEST AND MOST PROFITABLE WELLNESS AFFILIATE PROGRAM
FEATURING LIFETIME COMMISSIONS AND THE HIGHEST RE-ORDER RATE IN THE INDUSTRY
.



DISCLOSURE--NOTICE OF AFFILIATE/ADVERTISER STATUS:
The owner of this website is an affiliate/advertiser for providers of products and/or services listed on this website and may receive compensation if you purchase those products and/or services. All referrals are made in good faith for sources believed to be credible and that offer good value. In all cases the decision to purchase, or not to purchase, should be made after performing your own due-diligence on the efficacy and suitability of the product or service being offered. By clicking on product/service links on this website you agree to hold this website's owners harmless in the event the product/service is found to be unsuitable for any reason. All claims for refunds must be made to the supplier/vendor of any product/service you purchase from any link on this site..



Public Disclaimer For All Users :

Your use of this resource is your agreement not to hold WellnessArticleLibrary.com™ liable for the accuracy of any article on the site or on any partner sites and you agree to Hold Harmless WellnessArticleLibrary.com™, its owners, webmasters, internet hosts, etc. from any action arising from the publication of any article, or the content therein.

WellnessArticleLibrary.com™ is simply a hub for authors and publishers to meet and for end-users to benefit from the content included here.

WellnessArticleLibrary.com™ does not endorse any author, website, service, cause, or product mentioned in any articles. Articles published by WellnessArticleLibrary.com™ are not meant to be used for legal, medical, or any other type of advice. All articles are for informational and entertainment purposes only and are fully protected under the First Amendment of the United States Constitution and all applicable copyright laws.

Content and opinions in the articles on this site are the sole responsibility of the author. No article on this site purports to offer medical advise or makes any claims to any cure, treatment, or remediation of any disease or health condition. The articles on this site have not been reviewed or approved by the FDA. Due diligence should always be practiced by the reader and, in all cases, the reader is advised to seek assistance from a licensed professional when dealing with any diseases, ailments, health conditions, or concerns.





Powered by Article Dashboard